From idea, to lab, to clinic, to approval—it's a long and expensive process to bring a drug to market. It also rarely succeeds. Subscribe to our newsletter for the latest sci-tech news updates.

Noting that recent advances in artificial intelligence and the existence of large-scale experimental data about human biology have reached a critical mass, a team of researchers from Stanford ...